1. Home
  2. ADPT vs HELE Comparison

ADPT vs HELE Comparison

Compare ADPT & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
    SELLHOLDBUYas of 21 hours ago
  • HELE
    SELLHOLDBUYas of 21 hours ago
  • Stock Information
  • Founded
  • ADPT 2009
  • HELE 1968
  • Country
  • ADPT United States
  • HELE United States
  • Employees
  • ADPT N/A
  • HELE N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • HELE Home Furnishings
  • Sector
  • ADPT Health Care
  • HELE Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • HELE Nasdaq
  • Market Cap
  • ADPT 1.1B
  • HELE 1.3B
  • IPO Year
  • ADPT 2019
  • HELE N/A
  • Fundamental
  • Price
  • ADPT $7.43
  • HELE $53.49
  • Analyst Decision
  • ADPT Strong Buy
  • HELE Buy
  • Analyst Count
  • ADPT 5
  • HELE 3
  • Target Price
  • ADPT $9.40
  • HELE $79.67
  • AVG Volume (30 Days)
  • ADPT 2.2M
  • HELE 438.9K
  • Earning Date
  • ADPT 05-06-2025
  • HELE 04-23-2025
  • Dividend Yield
  • ADPT N/A
  • HELE N/A
  • EPS Growth
  • ADPT N/A
  • HELE N/A
  • EPS
  • ADPT N/A
  • HELE 4.95
  • Revenue
  • ADPT $178,957,000.00
  • HELE $1,910,975,000.00
  • Revenue This Year
  • ADPT $21.21
  • HELE N/A
  • Revenue Next Year
  • ADPT $21.98
  • HELE $6.22
  • P/E Ratio
  • ADPT N/A
  • HELE $10.81
  • Revenue Growth
  • ADPT 5.10
  • HELE N/A
  • 52 Week Low
  • ADPT $2.28
  • HELE $48.05
  • 52 Week High
  • ADPT $9.01
  • HELE $115.81
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 44.19
  • HELE 47.50
  • Support Level
  • ADPT $6.92
  • HELE $50.22
  • Resistance Level
  • ADPT $9.01
  • HELE $54.25
  • Average True Range (ATR)
  • ADPT 0.57
  • HELE 2.09
  • MACD
  • ADPT -0.01
  • HELE 0.40
  • Stochastic Oscillator
  • ADPT 24.58
  • HELE 82.53

Stock Price Comparison Chart: ADPT vs HELE

ADPT
HELE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160180200220240260ADPT VS HELE

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use